Company Legend Biotech Corporation

Equities

LEGN

US52490G1022

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-03-06 EST			5-day change	1st Jan Change
18.97 ^USD	+6.87%		-0.16%	-12.74%

02-23	Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion	RE
02-12	Legend Biotech Shares Lower After Rothschild & Co Redburn Downgrade	MT

Business description: Legend Biotech Corporation

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.

Number of employees: 2,900

Sales by Activity: Legend Biotech Corporation

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Biotechnology	78.75M	91.56M	117M	285M	627M

See all business segments

Geographical breakdown of sales: Legend Biotech Corporation

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
United States of America	-	86.37M	117M	270M	579M
Europe	-	-	-	15.07M	47.87M
China	-	3.42M	328K	179K	320K
North America	75.68M	-	-	-	-
Other	-	-	75K	-	-

See all geographic segments

Executive Committee: Legend Biotech Corporation

Manager	Title	Age	Since
Ying Huang CEO	Chief Executive Officer	53	2020-09-20
Mythili Koneru CTO	Chief Tech/Sci/R&D Officer	48	2023-04-10
Tracy Luo CTO	Chief Tech/Sci/R&D Officer	-	2018-04-30
Guowei Fang CTO	Chief Tech/Sci/R&D Officer	-	2022-02-28
Jessie Yeung DFI	Director of Finance/CFO	41	2025-01-01

See LEGEND BIOTECH CORPORATION governance

Composition of the Board of Directors: Legend Biotech Corporation

Director	Title	Age	Since
Ye Wang CHM	Chairman	57	2020-11-05
Ying Huang BRD	Director/Board Member	53	2021-12-29
Corazon Sanders BRD	Director/Board Member	69	2020-04-30
Xiao Hui Ji BRD	Director/Board Member	64	2020-04-30
Wai Man Yau BRD	Director/Board Member	50	2020-04-30
Li Zhu BRD	Director/Board Member	76	2020-11-22
Patrick Casey BRD	Director/Board Member	70	2020-12-02
Fang Liang Zhang CHM	Chairman	61	2015-05-26
Tomas Jan Heyman BRD	Director/Board Member	70	2022-08-01
Li Mao BRD	Director/Board Member	69	2022-08-01

Composition of the Board of Directors

Shareholders: Legend Biotech Corporation

Name	Equities	%	Valuation
Fidelity Management & Research Co. LLC 13.15 %	24,268,223	13.15 %	425 M $
Suvretta Capital Management LLC 3.581 %	6,608,629	3.581 %	116 M $
Westfield Capital Management Co. LP 3.34 %	6,164,677	3.34 %	108 M $
HHLR Advisors Ltd. (Cayman Islands) 3.242 %	5,984,550	3.242 %	105 M $
Deerfield Management Co. LP (Private Equity) 3.214 %	5,932,000	3.214 %	104 M $

Name	Equities	%	Valuation
GENSCRIPT BIOTECH CORPORATION 60.32 %	174,497,556	60.32 %	1 527 M $
Aquapoint LP 10.47 %	30,300,000	10.47 %	265 M $
Fang Liang Zhang 0.369 %	1,067,386	0.369 %	9 M $
Ying Huang 0.0741 %	214,364	0.0741 %	2 M $
Ye Wang 0.0583 %	168,642	0.0583 %	1 M $

List of LEGEND BIOTECH CORPORATION shareholders

Company details: Legend Biotech Corporation

Legend Biotech Corp.

2101 Cottontail Lane

08873, Somerset

+737 317 5050

http://www.legendbiotech.com

address Legend Biotech Corporation(LEGN)

Bio Therapeutic Drugs

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
LEGEND BIOTECH CORPORATION	+6.87%	-0.16%	-46.20%	-59.06%	3.5B
ARGENX SE	-0.61%	-5.35%	+12.03%	+92.93%	44.16B
WUXI APPTEC CO., LTD.	+0.92%	-4.81%	+49.26%	+14.90%	40.5B
INSMED INCORPORATED	-2.40%	-6.16%	+87.11%	+608.08%	30.21B
BIONTECH SE	-0.44%	-7.92%	-6.69%	-21.33%	25.47B
WUXI BIOLOGICS (CAYMAN) INC.	+2.54%	-9.65%	+53.01%	-34.70%	19.22B
GENMAB A/S	-2.62%	-6.49%	+4.16%	-31.60%	16.5B
AKESO, INC.	+5.20%	+0.37%	+47.19%	+154.57%	12.64B
SUMMIT THERAPEUTICS INC.	+1.14%	-8.92%	-15.02%	+994.93%	11.72B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+4.43%	-0.31%	+55.98%	-	11.51B
Average	+1.50%	-4.58%	+24.08%	+190.97%	21.54B
Weighted average by Cap.	+0.40%	-5.08%	+32.39%	+170.39%